Study of Human Brain-Gut Axis and Gut Microbiome in Patients With Brain Lesions - Repository for Neuroscience Research
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorMayo Clinic
About this trial
This study explores how microorganisms in the gut can affect the growth and progression of brain tumors.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
All patients undergoing resection for a tumor of the central nervous system and associated controls are eligible to participate in this study.
Disqualifiers
Excluded samples will be from patients younger than 18 years old. There are no exclusions due to race/sex.
Trial population
All patients undergoing resection for a tumor of the central nervous system and associated controls are eligible to participate in this study.
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
Non-Interventional Study
Other interventionNon-interventional study
Treatment groups
100 Participants
are divided into 1 treatment groupGroup A: Observational1 intervention
Trial outcomes
Primary outcomes
1
Establish the Mayo Clinic Florida Tumor-Gut Axis Biorepository
Biological samples such as stool, urine, blood, saliva, and/or tissue will be collected for storage in the Tumor-Gut Axis Biorepository. Samples may be collected at any of the following time periods during study participation: before/after steroid therapy, before/after surgical intervention, before/after radiation therapy, and before/after chemotherapy.
Time frame
Approximately 1 year, or until samples have been collected based on scheduled treatment.Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov